Novartis AG logo

Novartis AG - Cedear

NEW
BUE:NVS (Switzerland)   Cedear
ARS 60,575 -675 (-1.1%) Aug 12
23.57
P/B:
7.11
Market Cap:
ARS 433.94T ($ 290.75B)
Enterprise V:
ARS 496.15T ($ 332.43B)
Volume:
185.00
Avg Vol (2M):
393.00
Trade In:
Volume:
185.00
Avg Vol (2M):
393.00

Novartis AG’s share price is ARS60575. Its GF Value is ARS51644.82. Based on the relationship between the current stock price and the GF Value, GuruFocus believes Novartis AG stock is .

The GF Value represents the current intrinsic value of a stock derived from our proprietary algorithm. It is based primarily on the historical multiples of where the stocks have been traded and the future growth of the business, adjusted for the past returns and growth. The GF Value has been verified by backtesting and daily updated model portfolios.

GF Value Growth:

In addition to considering the current valuation, the growth potential of a company's value is equally important. Companies with faster growth rates tend to increase their value more quickly. Therefore, it's essential to look at the Price-to-Future GF Value ratios as well. The results are shown below:

Price: ARS60575 GF Value Price/GF Value
Current ARS51644.82 1.17
Next FY1 End ARS53005.56 1.14
Next 12 Month ARS55229.57 1.10
Next FY2 End ARS56341.58 1.08
Correlation Analysis
Summary:

GuruFocus performed a correlation analysis comparing Novartis AG's stock price with key financial metrics: revenue per share, book value per share, EPS without NRI, and operating cash flow per share.

The analysis reveals the strongest correlation between Novartis AG's stock price and Revenue per share, with a coefficient of 96%. This is followed by a 96% correlation with Book Value per share and a 94% correlation with Operating Cash Flow per share. The weakest correlation is observed with Operating Cash Flow per share, at 94%.

Historical Trends of Key Valuation Ratios
GF Value of Related Companies